Exact Mass: 428.123788

Exact Mass Matches: 428.123788

Found 46 metabolites which its exact mass value is equals to given mass value 428.123788, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Quizalofop-P-tefuryl

Quizalofop-P-tefuryl

C22H21ClN2O5 (428.11389260000004)


   

Eupachloroxin

Eupachloroxin

C20H25ClO8 (428.123788)


   

Eupachinilide E

Eupachinilide E

C20H25ClO8 (428.123788)


   

HMS1662J14

HMS1662J14

C18H19F3N4O5 (428.130748)


   

picraquassioside B

picraquassioside B

C19H24O11 (428.13185539999995)


   

(1alpha,2beta,3alpha)-Tribenzoyl-4-Cyclopentene-1,2,3-triol

(1alpha,2beta,3alpha)-Tribenzoyl-4-Cyclopentene-1,2,3-triol

C26H20O6 (428.125982)


   

(5E,8Z,14Z)-6-iodoicosa-5,8,14-trien-11-ynoic acid

(5E,8Z,14Z)-6-iodoicosa-5,8,14-trien-11-ynoic acid

C20H29IO2 (428.12122039999997)


   

canthin-6-one-9-methoxy-5-O-beta-D-glucopyranoside

canthin-6-one-9-methoxy-5-O-beta-D-glucopyranoside

C21H20N2O8 (428.12196)


   

duramidine D

duramidine D

C20H20N4O7 (428.133193)


   

Yadanziolide A

Yadanziolide A

C19H24O11 (428.13185539999995)


   

neopargueroldione

neopargueroldione

C20H29BrO5 (428.1198244)


   

C21H20N2O8

C21H20N2O8 (428.12196)


   

Cys Cys Phe Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]acetic acid

C17H24N4O5S2 (428.1188054)


   

Cys Cys Gly Phe

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-3-phenylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Cys Phe Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]acetic acid

C17H24N4O5S2 (428.1188054)


   

Cys Phe Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]acetamido}-3-sulfanylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Cys Gly Cys Phe

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-3-phenylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Cys Gly Phe Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-phenylpropanamido]-3-sulfanylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Phe Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C17H24N4O5S2 (428.1188054)


   

Phe Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Phe Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Gly Cys Cys Phe

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Gly Cys Phe Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Gly Phe Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H24N4O5S2 (428.1188054)


   

Phenytoin-N-glucuronide

Phenytoin-N-glucuronide

C21H20N2O8 (428.12196)


   

2,2-bipyridyl-4,4-diphosphonic ethyl ester

2,2-bipyridyl-4,4-diphosphonic ethyl ester

C18H26N2O6P2 (428.1266036)


   

5-cyano-N-[[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]carbamoyl]-6-(4-methylphenyl)sulfanylpyridine-3-carboxamide

5-cyano-N-[[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]carbamoyl]-6-(4-methylphenyl)sulfanylpyridine-3-carboxamide

C20H20N4O5S (428.11543500000005)


   

2-benzofuran-1,3-dione,furan-2,5-dione,2-(2-hydroxyethoxy)ethanol,propane-1,2-diol

2-benzofuran-1,3-dione,furan-2,5-dione,2-(2-hydroxyethoxy)ethanol,propane-1,2-diol

C19H24O11 (428.13185539999995)


   

Benzoic acid, 2-((3S,4R)-3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl)-4-(trifluoromethyl)-

Benzoic acid, 2-((3S,4R)-3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl)-4-(trifluoromethyl)-

C24H19F3O4 (428.12353700000006)


   

3-Phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-YL]carbonyl}amino)propanoic acid

3-Phenyl-3-({[4-(4-pyridin-4-ylphenyl)thien-2-YL]carbonyl}amino)propanoic acid

C25H20N2O3S (428.119457)


   

Pantera

Pantera

C22H21ClN2O5 (428.11389260000004)


   

methyl 2-[2-chloro-6-ethoxy-4-[(Z)-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)methyl]phenoxy]acetate

methyl 2-[2-chloro-6-ethoxy-4-[(Z)-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)methyl]phenoxy]acetate

C22H21ClN2O5 (428.11389260000004)


SJ-172550 is a small molecule inhibitor of MDMX; competes for the wild type p53 peptide binding to MDMX with an EC50 of 5 μM.

   

[Pks-acp]-group

[Pks-acp]-group

C14H27N3O8PS- (428.1256412)


   

ethyl {1-[(9-methyl-4-oxo-4H-pyrido[1,2-a]thieno[2,3-d]pyrimidin-2-yl)carbonyl]-3-oxopiperazin-2-yl}acetate

ethyl {1-[(9-methyl-4-oxo-4H-pyrido[1,2-a]thieno[2,3-d]pyrimidin-2-yl)carbonyl]-3-oxopiperazin-2-yl}acetate

C20H20N4O5S (428.11543500000005)


   

3-[(7,8-dimethyl-2-oxo-1-benzopyran-4-yl)methoxy]-N,N-dimethyl-5-benzotriazolesulfonamide

3-[(7,8-dimethyl-2-oxo-1-benzopyran-4-yl)methoxy]-N,N-dimethyl-5-benzotriazolesulfonamide

C20H20N4O5S (428.11543500000005)


   

1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone

1-[4-(Benzenesulfonyl)-1-piperazinyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone

C20H20N4O5S (428.11543500000005)


   

1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-[[2-(phenylmethyl)-4-quinazolinyl]thio]ethanone

1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-[[2-(phenylmethyl)-4-quinazolinyl]thio]ethanone

C25H20N2O3S (428.119457)


   

(6S,7R,8R)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

C22H21FN2O4S (428.12059980000004)


   

(6S,7S,8R)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

C22H21FN2O4S (428.12059980000004)


   

(6S,7S,8S)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

C22H21FN2O4S (428.12059980000004)


   

(6R,7R,8S)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

C22H21FN2O4S (428.12059980000004)


   

(6R,7R,8R)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-[2-(4-fluorophenyl)ethynyl]phenyl]-8-(hydroxymethyl)-4-methylsulfonyl-1,4-diazabicyclo[4.2.0]octan-2-one

C22H21FN2O4S (428.12059980000004)


   

6-[2-(Carboxymethyl)-3,5-dihydroxy-4-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[2-(Carboxymethyl)-3,5-dihydroxy-4-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C19H24O11 (428.13185539999995)


   

6-[4-(Carboxymethyl)-3,5-dihydroxy-2-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[4-(Carboxymethyl)-3,5-dihydroxy-2-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C19H24O11 (428.13185539999995)


   

ST 19:4;O6;S

ST 19:4;O6;S

C19H24O9S (428.1140974)


   

Valopicitabine (dihydrochloride)

Valopicitabine (dihydrochloride)

C15H26Cl2N4O6 (428.1229316)


Valopicitabine (NM283) dihydrochloride is a nucleoside analog and the orally bioavailable proagent of the potent anti-HCV agent 2'-C-methylcytidine (NM107). NM107competitively inhibits NS5B polymerase, causing chain termination[1][2].